NASDAQ:ATEC Alphatec (ATEC) Stock Price, News & Analysis $8.24 +0.02 (+0.24%) Closing price 04:00 PM EasternExtended Trading$8.17 -0.07 (-0.81%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Alphatec Stock (NASDAQ:ATEC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alphatec alerts:Sign Up Key Stats Today's Range$7.98▼$8.3350-Day Range$6.99▼$13.0552-Week Range$6.82▼$23.29Volume2.02 million shsAverage Volume5.09 million shsMarket Capitalization$1.27 billionP/E RatioN/ADividend YieldN/APrice Target$18.58Consensus RatingModerate Buy Company Overview Alphatec Holdings, Inc. (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries. Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market. Alphatec has introduced technologies such as the iGAINS® implant for adjustable anatomical fit and the SONICanchor® fixation system to enhance implant stability. Its proprietary OsteoStrand™ biologic portfolio supports bone growth through versatile carrier options, reflecting the company’s emphasis on combining mechanical and biological approaches to fusion. Alphatec serves a broad patient base across North America, with expanding footprints in Europe, Latin America and select Asia-Pacific markets. The company collaborates with hospitals, ambulatory surgery centers and specialty spine centers, providing training and support services to surgeons adopting its technologies. Regional distribution agreements and direct sales channels aim to ensure consistent product availability and clinical support worldwide. Under the leadership of President and Chief Executive Officer William J. Dickerson, Alphatec has pursued strategic partnerships and targeted acquisitions to diversify its technology pipeline. The senior management team brings experience in medical device commercialization, regulatory affairs and global operations. With ongoing investments in research and development, Alphatec continues to advance its next-generation systems and digital planning tools to address evolving surgical needs in spine care.AI Generated. May Contain Errors. Read More Alphatec Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreATEC MarketRank™: Alphatec scored higher than 73% of companies evaluated by MarketBeat, and ranked 193rd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingAlphatec has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 10 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialAlphatec has a consensus price target of $18.58, representing about 125.5% upside from its current price of $8.24.Amount of Analyst CoverageAlphatec has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Alphatec's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($0.44) to $0.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -10.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -10.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Alphatec's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.96% of the float of Alphatec has been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 4.13.Change versus previous monthShort interest in Alphatec has recently decreased by 15.16%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. News and Social Media2.4 / 5News Sentiment-0.21 News SentimentAlphatec has a news sentiment score of -0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for Alphatec this week, compared to 5 articles on an average week.Search Interest13 people have searched for ATEC on MarketBeat in the last 30 days. This is an increase of 160% compared to the previous 30 days.MarketBeat Follows2 people have added Alphatec to their MarketBeat watchlist in the last 30 days. Company Ownership1.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $7,801,589.00 in company stock.Percentage Held by Insiders13.48% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.35% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alphatec's insider trading history. Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ATEC Stock News HeadlinesATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.May 19 at 7:00 PM | businesswire.comAlphatec - Slower Growth Seems Priced In HereMay 19 at 12:03 PM | seekingalpha.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.May 20 at 1:00 AM | Profits Run (Ad)INVESTOR ALERT: Investigation of Alphatec Holdings, Inc. (ATEC) announced by Holzer & Holzer, LLCMay 18 at 8:00 AM | globenewswire.comSecurities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading ...May 16, 2026 | tmcnet.comAlphatec Holdings, Inc. (ATEC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 15, 2026 | tmcnet.comAlphatec Holdings, Inc. (ATEC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationMay 15, 2026 | businesswire.comSecurities Fraud Investigation Into Alphatec Holdings, Inc. (ATEC) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzMay 14, 2026 | tmcnet.comSee More Headlines ATEC Stock Analysis - Frequently Asked Questions How have ATEC shares performed this year? Alphatec's stock was trading at $21.04 at the start of the year. Since then, ATEC shares have decreased by 60.8% and is now trading at $8.24. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) posted its earnings results on Tuesday, May, 5th. The medical technology company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.21. Alphatec's revenue was up 13.6% compared to the same quarter last year. Read the conference call transcript. Who are Alphatec's major shareholders? Alphatec's top institutional shareholders include Bank of America Corp DE (1.67%), Emerald Advisers LLC (1.18%), Granite Investment Partners LLC (0.79%) and Emerald Mutual Fund Advisers Trust (0.75%). Insiders that own company stock include Squadron Capital Llc, Jennifer N Pritzker, David R Pelizzon, Patrick Miles, Craig E Hunsaker, Scott Lish, Mortimer Berkowitz III, Tyson Eliot Marshall, David Sponsel, David M Demski, John Todd Koning, Jeffrey P Rydin, Paul Segal, David H Mowry and Evan Bakst. View institutional ownership trends. How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alphatec investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Meta Platforms (META). Company Calendar Last Earnings5/05/2026Today5/20/2026Next Earnings (Estimated)7/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 ATEC's financial health is in the Red zone, according to TradeSmith. ATEC has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:ATEC CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees700Year Founded1990Price Target and Rating Average Price Target for Alphatec$18.58 High Price Target$25.00 Low Price Target$11.00 Potential Upside/Downside+125.5%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$143.36 million Net Margins-15.93% Pretax Margin-15.92% Return on Equity-1,183.84% Return on Assets-15.83% Debt Debt-to-Equity Ratio40.35 Current Ratio1.90 Quick Ratio1.12 Sales & Book Value Annual Sales$764.16 million Price / Sales1.66 Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-274.67Miscellaneous Outstanding Shares153,790,000Free Float133,058,000Market Cap$1.27 billion OptionableOptionable Beta0.96 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:ATEC) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alphatec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
